Markus A. Loeven

491 total citations
12 papers, 386 citations indexed

About

Markus A. Loeven is a scholar working on Hematology, Nephrology and Cell Biology. According to data from OpenAlex, Markus A. Loeven has authored 12 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Nephrology and 5 papers in Cell Biology. Recurrent topics in Markus A. Loeven's work include Platelet Disorders and Treatments (6 papers), Cell Adhesion Molecules Research (4 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Markus A. Loeven is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Cell Adhesion Molecules Research (4 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Markus A. Loeven collaborates with scholars based in Netherlands, United Kingdom and United States. Markus A. Loeven's co-authors include Johan van der Vlag, Jo H. M. Berden, Elmar Pieterse, Marjolein Garsen, Hanneke Knaapen, Luuk B. Hilbrands, Markus Hoffmann, Julia M. Hofstra, Olivier W.H. van der Heijden and Simon C. Satchell and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Markus A. Loeven

12 papers receiving 385 citations

Peers

Countries citing papers authored by Markus A. Loeven

Since Specialization

Citations

This map shows the geographic impact of Markus A. Loeven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus A. Loeven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus A. Loeven more than expected).

Fields of papers citing papers by Markus A. Loeven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus A. Loeven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus A. Loeven. The network helps show where Markus A. Loeven may publish in the future.

Co-authorship network of co-authors of Markus A. Loeven

This figure shows the co-authorship network connecting the top 25 collaborators of Markus A. Loeven. A scholar is included among the top collaborators of Markus A. Loeven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus A. Loeven. Markus A. Loeven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis 2021 ·PLoS ONE ·Jasper J. van Gemst, (unknown), Angelique L. Rops, Toin H. Van Kuppevelt, Jo H. M. Berden, Markus A. Loeven, Ton J. Rabelink, Bart Smeets, Johan van der Vlag	2
2	Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies 2021 ·Frontiers in Immunology ·Markus A. Loeven, Marissa L. Maciej-Hulme, Cansu Yanginlar, (unknown), Edwin Kellenbach, (unknown), Toin H. Van Kuppevelt, Jack F.M. Wetzels, Ton J. Rabelink, Richard J. Smith, Johan van der Vlag	9
3	Inhibition of mTOR delayed but could not prevent experimental collapsing focal segmental glomerulosclerosis 2020 ·Scientific Reports ·(unknown), (unknown), Shagun Sharma, Markus A. Loeven, Brigith Willemsen, (unknown), Fieke Mooren, Catherine Meyer‐Schwesinger, Henry Dijkman, Jack F.M. Wetzels, Jitske Jansen, Johan van der Vlag, Bart Smeets	4
4	Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains 2018 ·PLoS ONE ·Jasper J. van Gemst, (unknown), Angelique L. Rops, Toin H. Van Kuppevelt, Jo H. M. Berden, Ton J. Rabelink, Markus A. Loeven, Johan van der Vlag	12
5	A Novel Choroidal Endothelial Cell Line Has a Decreased Affinity for the Age-Related Macular Degeneration–Associated Complement Factor H Variant 402H 2018 ·Investigative Ophthalmology & Visual Science ·Markus A. Loeven, Jasper J. van Gemst, Carolien M. S. Schophuizen, Viranga Tilakaratna, Lambert P. van den Heuvel, Anthony J. Day, B. Jeroen Klevering, Johan van der Vlag	11
6	Neutrophil Extracellular Traps Drive Endothelial-to-Mesenchymal Transition 2017 ·Arteriosclerosis Thrombosis and Vascular Biology ·Elmar Pieterse, Nils Rother, Marjolein Garsen, Julia M. Hofstra, Simon C. Satchell, Markus Hoffmann, Markus A. Loeven, Hanneke Knaapen, Olivier W.H. van der Heijden, Jo H. M. Berden, Luuk B. Hilbrands, Johan van der Vlag	196
7	CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis 2017 ·Kidney International ·(unknown), Shagun Sharma, Markus A. Loeven, Jack F.M. Wetzels, Fieke Mooren, Sandrine Florquin, Jeroen K. Deegens, Brigith Willemsen, Vikram Sharma, Toin H. Van Kuppevelt, Marinka A.H. Bakker, Tammo Ostendorf, Marcus J. Moeller, Henry Dijkman, Bart Smeets, Johan van der Vlag	48
8	Panels of chemically-modified heparin polysaccharides and natural heparan sulfate saccharides both exhibit differences in binding to Slit and Robo, as well as variation between protein binding and cellular activity 2016 ·Molecular BioSystems ·Yassir Ahmed, Edwin A. Yates, Diana Moss, Markus A. Loeven, Sadaf‐Ahmahni Hussain, Erhard Hohenester, Jeremy E. Turnbull, Andrew K. Powell	8
9	Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro 2016 ·Journal of Biological Chemistry ·Markus A. Loeven, Angelique L. Rops, Markus J. Lehtinen, Toin H. Van Kuppevelt, Mohamed R. Daha, Richard J. Smith, Marinka A.H. Bakker, Jo H. M. Berden, Ton J. Rabelink, T. Sakari Jokiranta, Johan van der Vlag	19
10	RNA Contaminates Glycosaminoglycans Extracted from Cells and Tissues 2016 ·PLoS ONE ·Jasper J. van Gemst, Markus A. Loeven, (unknown), Jo H. M. Berden, Ton J. Rabelink, (unknown), Johan van der Vlag	12
11	The role of heparan sulfate as determining pathogenic factor in complement factor H-associated diseases 2014 ·Molecular Immunology ·Markus A. Loeven, Angelique L. Rops, Jo H. M. Berden, Mohamed R. Daha, Ton J. Rabelink, Johan van der Vlag	22
12	Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis 2014 ·Kidney International ·Angelique L. Rops, Markus A. Loeven, Jasper J. van Gemst, (unknown), (unknown), Henry Dijkman, Toin H. Van Kuppevelt, Jo H. M. Berden, Ton J. Rabelink, Jeffrey D. Esko, Johan van der Vlag	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact